Skip to content
Profiles

Kevin Marks

Kevin, a seasoned legal professional, joins the CMTA Board with a wealth of experience in the drug development arena. Currently serving as Chief Legal Officer at Parker Institute for Cancer Immunotherapy (PICI), Kevin oversees legal, intellectual property, and human resources matters. With a background in therapeutics and diagnostics sectors, Kevin brings extensive expertise in legal and compliance issues, as well as sponsored research. Personally impacted by CMT, Kevin is dedicated to advancing the CMTA’s mission and contributing his legal acumen to propel the organization’s efforts forward.

CMTA board member Kevin Marks